Перевести на Переведено сервисом «Яндекс.Перевод»

Sequenom

Country
USA
Краткое название
Sequenom
Headquarters
3595 John Hopkins Court
Members of the board

Harry F. Hixson Jr., Ph.D. — Chief Executive Officer  
William Welch, M.B.A. — President and Chief Operating Officer  
Ronald M. Lindsay, Ph.D. — Executive Vice President, Strategic Planning   
Dirk van den Boom, Ph.D. — Executive Vice President, Research & Development and Chief Technology Officer  
Allan T. Bombard, M.D. — Chief Medical Officer  
Charles R. Cantor, Ph.D. — Chief Scientific Officer  
Carolyn D. Beaver — Vice President and Chief Accounting Officer  
Paul Maier — Chief Financial Officer  
Michael Monko, M.B.A. — Senior Vice President, Genetic Analysis  
Bill Bowen, J.D. — Senior Vice President and General Counsel  
Robin Weiner — Senior Vice President, Regulatory Affairs & Quality  
Alisa Judge — Vice President, Human Resources

Categories medicine
Obstetrics & Gynaecology, Oncology, Infectious diseases, Ophthalmology
Stage of the project
Production
Disease
Williams syndrome, Glaucoma, Influenza, Thyroid and vascular gland cancer, Pregnancy
Ticker
SQNM
Current owners

Ernst-Günter Afting, Ph.D., M.D.
Kenneth F. Buechler, Ph.D.
John A. Fazio
David Pendarvis, Esq.
Harry F. Hixson, Jr., Ph.D.
Myla Lai-Goldman, M.D.
Richard A. Lerner, M.D.
Charles P. Slacik
Ronald M. Lindsay, Ph.D.

Assets
368.4600
Technology
Bioengineering, Cell Technologies, Devices, Services, Technologies, Chemistry